EU → North America Device Access

IBL International GmbH

DE-MF-000015709 · Germany · Hamburg

IBL International GmbH is registered in the European database on medical devices as a manufacturer, with 148 devices declared. It is also registered as a device establishment with the U.S. FDA.

What this manufacturer declares

Devices declared under this manufacturer

Showing 12 of 148 declared devices.

Catalogue references include 30132293, DB52161, MG11101, RE54031, RE57201, RE69981.

European nomenclature codes declared: W0102050110, W0102050102, W0102060601, W0102050106, W0102050103, W0102069003.

United States market access

FDA establishment registerRegistered with FDA
Matched entryIBL INTERNATIONAL GMBH (DE) · FDA 9710337
Devices in EUDAMED148
Country of registrationGermany

Device-level evidence

Devices with a numeric GTIN148
Found in the U.S. device database6
Share4.1 %

Canadian market access

Health Canada licence listingLicensed in Canada
Matched entryIBL INTERNATIONAL GMBH

What it holds in Canada

Licences on record20
Currently active0
Class 2 devices20
First licensed2007-11-21

Licence types: Test Kit (20).

Licensed under: 17-OH-PROGESTERONE ELISA, ACETYLCHOLINE RECEPTOR AUTOANTIBODIES (ARAB) R, SEROTONIN ELISA, MELATONIN-SULFATE URINE ELISA, MELATONIN ELISA, HISTAMINE ELISA.

North American profile: Both markets. IBL International GmbH is registered in both the United States and Canada.

Other manufacturers in Germany

All Germany manufacturers →